IV Tramadol – A New Treatment Option for Management of Post-Operative Pain in the US: An Open-Label, Single-Arm, Safety Trial Including Various Types of Surgery

PURPOSE: There is a need to reduce exposure to Schedule II opioids in the United States (US) due to the ongoing opioid epidemic. Schedule II opioids have higher potential for abuse and misuse than Schedule IV opioids. This Phase 3, multicenter, single-arm, open-label, multiple-dose US trial evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Minkowitz, Harold, Leiman, David, Lu, Lucy, Reines, Scott, Ryan, Michael, Harnett, Mark, Singla, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250287/
https://www.ncbi.nlm.nih.gov/pubmed/32547178
http://dx.doi.org/10.2147/JPR.S251175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250287/
https://www.ncbi.nlm.nih.gov/pubmed/32547178
http://dx.doi.org/10.2147/JPR.S251175

Ejemplares similares